Abstract:Objective: In-stent restenosis (ISR) and stent compression (SC) are problems encountered after stenting for chronic iliofemoral venous obstruction that are responsible for a majority of reinterventions. However, characteristics of ISR and SC, in addition to outcomes after reintervention, have not been explored in detail and represent the focus of this study. Methods: A retrospective analysis of contemporaneously entered electronic medical record data on 578 limbs/patients with initial unilateral iliofemoral venous stents placed from 2014 to 2018 was performed. ISR was estimated from stent and flow channel diameters measured using duplex ultrasound. SC was estimated from rated stent diameter and actual stent diameter on duplex ultrasound. Characteristics evaluated included onset of ISR/SC after stent placement and progression over time. Analysis was performed to evaluate risk factors for the development of ISR and SC. Outcomes after reintervention for ISR/SC were also appraised. Results: A total of 578 limbs underwent stenting for stenotic lesions (nonthrombotic iliac vein lesion/post-thrombotic syndrome). ISR was noted in 27% of limbs on post-intervention day 1. The prevalence of ISR increased to 74% by 3 months and stabilized thereafter. SC was noted in 80% of limbs on day 1 and plateaued. Of the variables evaluated as potential risk factors for ISR, intravascular ultrasound determined stent inflow luminal area and shear rate were found to be significant. For SC, asymmetric stent sizing was a significant risk factor. Over a median follow-up of 24 months, 95 of 578 (16.4%) limbs underwent reintervention for ISR, SC, or a combination. The median time to reintervention was 11 months. There was no statistically significant difference in the degree of ISR/SC among patients who underwent reintervention vs those who did not (P > .05). However, there was a statistically significant difference in the grade of swelling (P = .006) and visual analog scale pain scores (P < .0001) between those who underwent reintervention and those who did not. Primary, primary assisted, and secondary patencies at 60 months were 70%, 98%, and 84% after reintervention for ISR and 70%, 99%, and 84% for SC, respectively. Conclusions: Although ISR and SC are both common after stenting for chronic iliofemoral venous obstruction, neither are relentlessly progressive. Indication for reintervention must be a recurrence of symptoms with impairment of quality of life and not the percentage of ISR or degree of SC. After reintervention good outcomes can be expected both in terms of clinical improvement and stent patency. Further study of the impact of shear rate on stent flow is required to help reduce the incidence of ISR.

Minimal vessel area predicts in-stent restenosis in nonthrombotic iliac vein compression syndrome after stenting

Predictors of in-stent stenosis and occlusion after endovascular treatment of intracranial vascular disease with the Willis covered stent.

[Antithrombotic therapy after iliac vein stenting].

The effect of stent compression on in-stent restenosis and clinical outcomes in iliac vein compression syndrome.

A systematic review of DVT and stent restenosis after stent implantation for iliac vein compression syndrome

Insights from Computational Fluid Dynamics and In Vitro Studies for Stent Protrusion in Iliac Vein: How Far Shall We Go?

Clinical Outcomes at 3 Years After Stenting for Thrombotic and Non-thrombotic Iliac Vein Compression Syndrome Patients

Impact of Lower Limb Movements on Iliac Vein Stenting in Iliac Vein Compression Syndrome Patients: Insights from Computational Modeling

Midterm Results of Endovascular Treatment for Iliac Vein Compression Syndrome from a Single Center

Mechanism of effect of stenting on hemodynamics at iliac vein bifurcation

Three-Year Outcomes, Risk Factors for Restenosis After Stenting for DVT Combined with Iliac Vein Compression Syndrome

Endovascular Treatment for Symptomatic Iliac Vein Compression Syndrome: a Prospective Consecutive Series of 48 Patients.

Influence of Vessel Size and Tortuosity on In-Stent Restenosis after Stent Implantation in the Vertebral Artery Ostium.

In-stent recurrent stenosis in stents placed in the lower extremity venous outflow tract

In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction

The Meaning of Imaging Characteristics in the Severity of Iliac Vein Compression Syndrome

Long-term Follow-Up of the Stenting Across the Iliocaval Confluence in Patients with Iliac Venous Lesions

Etiology of iliocaval stent thrombosis

Endovascular Treatment of Iliac Vein Compression Syndrome.

Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting

Management of Iliofemoral Venous Stent Thrombosis